Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study.
Jithin MathewSiddharth JainTerence SusngiGodasi Srsnk NaiduArghya ChattopadhyayAman SharmaSanjay JainShefali Khanna SharmaPublished in: Rheumatology advances in practice (2023)
The presence of co-morbidities was independently associated with COVID-19 severity and hospitalization. Ongoing rheumatic disease activity and the presence of lupus or SSc independently predicted mortality. Age, sex, type of immunosuppressive therapy and presence of RMD-associated interstitial lung disease did not affect COVID-19 severity or outcomes in Indian RMD patients.
Keyphrases
- disease activity
- rheumatoid arthritis
- coronavirus disease
- interstitial lung disease
- sars cov
- systemic lupus erythematosus
- systemic sclerosis
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- ejection fraction
- newly diagnosed
- juvenile idiopathic arthritis
- chronic kidney disease
- respiratory syndrome coronavirus
- prognostic factors
- cardiovascular events
- idiopathic pulmonary fibrosis
- bone marrow
- skeletal muscle
- weight loss
- insulin resistance
- replacement therapy